These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17272827)

  • 1. A simple strategy for mitigating the effect of data variability on the identification of active chemotypes from high-throughput screening data.
    Johnson SR; Padmanabha R; Vaccaro W; Hermsmeier M; Cacace A; Lawrence M; Dickey J; Esposito K; Pike K; Wong V; Poss M; Loughney D; Tebben A
    J Biomol Screen; 2007 Mar; 12(2):276-84. PubMed ID: 17272827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput determination of mode of inhibition in lead identification and optimization.
    Wei M; Wynn R; Hollis G; Liao B; Margulis A; Reid BG; Klabe R; Liu PC; Becker-Pasha M; Rupar M; Burn TC; McCall DE; Li Y
    J Biomol Screen; 2007 Mar; 12(2):220-8. PubMed ID: 17351185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical approaches to efficient screening: information-rich screening protocol.
    Karnachi PS; Brown FK
    J Biomol Screen; 2004 Dec; 9(8):678-86. PubMed ID: 15634794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reading dynamic kinase activity in living cells for high-throughput screening.
    Allen MD; DiPilato LM; Rahdar M; Ren YR; Chong C; Liu JO; Zhang J
    ACS Chem Biol; 2006 Jul; 1(6):371-6. PubMed ID: 17163774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An offline-addition format for identifying GPCR modulators by screening 384-well mixed compounds in the FLIPR.
    Gopalakrishnan SM; Mammen B; Schmidt M; Otterstaetter B; Amberg W; Wernet W; Kofron JL; Burns DJ; Warrior U
    J Biomol Screen; 2005 Feb; 10(1):46-55. PubMed ID: 15695343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Plate cherry picking": a novel semi-sequential screening paradigm for cheaper, faster, information-rich compound selection.
    Crisman TJ; Jenkins JL; Parker CN; Hill WA; Bender A; Deng Z; Nettles JH; Davies JW; Glick M
    J Biomol Screen; 2007 Apr; 12(3):320-7. PubMed ID: 17438067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Readout technologies for highly miniaturized kinase assays applicable to high-throughput screening in a 1536-well format.
    Klumpp M; Boettcher A; Becker D; Meder G; Blank J; Leder L; Forstner M; Ottl J; Mayr LM
    J Biomol Screen; 2006 Sep; 11(6):617-33. PubMed ID: 16760365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
    Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
    J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A kinase-focused compound collection: compilation and screening strategy.
    Sun D; Chuaqui C; Deng Z; Bowes S; Chin D; Singh J; Cullen P; Hankins G; Lee WC; Donnelly J; Friedman J; Josiah S
    Chem Biol Drug Des; 2006 Jun; 67(6):385-94. PubMed ID: 16882313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual screen for ligands of orphan G protein-coupled receptors.
    Bock JR; Gough DA
    J Chem Inf Model; 2005; 45(5):1402-14. PubMed ID: 16180917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-high-throughput screening analysis: an empirical compound prioritization scheme.
    Oprea TI; Bologa CG; Edwards BS; Prossnitz ER; Sklar LA
    J Biomol Screen; 2005 Aug; 10(5):419-26. PubMed ID: 16093551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using clustering techniques to improve hit selection in high-throughput screening.
    Gagarin A; Makarenkov V; Zentilli P
    J Biomol Screen; 2006 Dec; 11(8):903-14. PubMed ID: 17092911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel method for analyzing [Ca2+] flux kinetics in high-throughput screening.
    Gribbon P; Chambers C; Palo K; Kupper J; Mueller J; Sewing A
    J Biomol Screen; 2006 Aug; 11(5):511-8. PubMed ID: 16760374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel statistical approach for primary high-throughput screening hit selection.
    Yan SF; Asatryan H; Li J; Zhou Y
    J Chem Inf Model; 2005; 45(6):1784-90. PubMed ID: 16309285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A fluorescence lifetime based binding assay to characterize kinase inhibitors.
    Lebakken CS; Hee Chol Kang ; Vogel KW
    J Biomol Screen; 2007 Sep; 12(6):828-41. PubMed ID: 17644772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further comparison of primary hit identification by different assay technologies and effects of assay measurement variability.
    Wu X; Sills MA; Zhang JH
    J Biomol Screen; 2005 Sep; 10(6):581-9. PubMed ID: 16103421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of cluster structure-activity relationship analysis in efficient high-throughput screening.
    Wang XS; Salloum GA; Chipman HA; Welch WJ; Young SS
    J Chem Inf Model; 2007; 47(3):1206-14. PubMed ID: 17480051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient method for high-throughput virtual screening based on flexible docking: discovery of novel acetylcholinesterase inhibitors.
    Mizutani MY; Itai A
    J Med Chem; 2004 Sep; 47(20):4818-28. PubMed ID: 15369385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay.
    Meng T; Su HR; Binkert C; Fischli W; Zhou L; Shen JK; Wang MW
    Acta Pharmacol Sin; 2008 Apr; 29(4):517-27. PubMed ID: 18358099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplexing fluorescence polarization assays to increase information content per screen: applications for screening steroid hormone receptors.
    Blommel P; Hanson GT; Vogel KW
    J Biomol Screen; 2004 Jun; 9(4):294-302. PubMed ID: 15191646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.